Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 18.81
(9.49%)
CNY 18.81
(9.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 711.43 Million CNY | 7.19% |
| 2022 | 553.97 Million CNY | -10.45% |
| 2021 | 595.34 Million CNY | -5.28% |
| 2020 | 634.12 Million CNY | 52.63% |
| 2019 | 378.85 Million CNY | 46.66% |
| 2018 | 277.43 Million CNY | 4.99% |
| 2017 | 252.05 Million CNY | -3.22% |
| 2016 | 267.88 Million CNY | 38.52% |
| 2015 | 199.09 Million CNY | 142.31% |
| 2014 | 82.64 Million CNY | -62.47% |
| 2013 | 215.33 Million CNY | 5.4% |
| 2012 | 209.56 Million CNY | 20.48% |
| 2011 | 173.79 Million CNY | 33.0% |
| 2010 | 133.71 Million CNY | 20.18% |
| 2009 | 109.51 Million CNY | 40.22% |
| 2008 | 78.87 Million CNY | 31.21% |
| 2007 | 59.81 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 122.36 Million CNY | -8.44% |
| 2024 Q1 | 106.72 Million CNY | -45.25% |
| 2024 Q2 | 118.33 Million CNY | -14.63% |
| 2023 Q4 | 109 Million CNY | -10.05% |
| 2023 FY | - CNY | 7.19% |
| 2023 Q1 | 93.85 Million CNY | -27.42% |
| 2023 Q2 | 120.01 Million CNY | 27.88% |
| 2023 Q3 | 121.18 Million CNY | 0.97% |
| 2022 FY | - CNY | -10.45% |
| 2022 Q4 | 129.31 Million CNY | 5.27% |
| 2022 Q3 | 122.83 Million CNY | 34.6% |
| 2022 Q2 | 91.26 Million CNY | 1.3% |
| 2022 Q1 | 90.09 Million CNY | -34.12% |
| 2021 Q3 | 112.73 Million CNY | 5.4% |
| 2021 Q4 | 136.75 Million CNY | 21.31% |
| 2021 Q2 | 106.96 Million CNY | -35.22% |
| 2021 FY | - CNY | -5.28% |
| 2021 Q1 | 165.12 Million CNY | -9.52% |
| 2020 Q4 | 182.48 Million CNY | 27.36% |
| 2020 FY | - CNY | 52.63% |
| 2020 Q1 | 108.25 Million CNY | 6.15% |
| 2020 Q2 | 117.57 Million CNY | 8.61% |
| 2020 Q3 | 143.28 Million CNY | 21.87% |
| 2019 Q1 | 76.41 Million CNY | 191.41% |
| 2019 Q4 | 101.97 Million CNY | 16.63% |
| 2019 FY | - CNY | 46.66% |
| 2019 Q3 | 87.43 Million CNY | 30.51% |
| 2019 Q2 | 67 Million CNY | -12.32% |
| 2018 Q3 | 54.38 Million CNY | 9.32% |
| 2018 FY | - CNY | 4.99% |
| 2018 Q1 | 67.06 Million CNY | 113.18% |
| 2018 Q2 | 49.75 Million CNY | -25.82% |
| 2018 Q4 | 26.22 Million CNY | -51.79% |
| 2017 Q4 | 31.46 Million CNY | -45.92% |
| 2017 FY | - CNY | -3.22% |
| 2017 Q1 | 46.09 Million CNY | -16.08% |
| 2017 Q2 | 50.91 Million CNY | 10.46% |
| 2017 Q3 | 58.17 Million CNY | 14.26% |
| 2016 FY | - CNY | 38.52% |
| 2016 Q4 | 54.92 Million CNY | -22.7% |
| 2016 Q3 | 71.05 Million CNY | 64.68% |
| 2016 Q2 | 43.14 Million CNY | 2.46% |
| 2016 Q1 | 42.1 Million CNY | -26.12% |
| 2015 Q2 | 27.34 Million CNY | -18.47% |
| 2015 FY | - CNY | 142.31% |
| 2015 Q3 | 45.83 Million CNY | 67.63% |
| 2015 Q4 | 56.99 Million CNY | 24.35% |
| 2015 Q1 | 33.53 Million CNY | 8001.51% |
| 2014 Q1 | 24.34 Million CNY | -68.03% |
| 2014 FY | - CNY | -62.47% |
| 2014 Q3 | 9.42 Million CNY | -38.31% |
| 2014 Q2 | 15.27 Million CNY | -37.25% |
| 2014 Q4 | 413.98 Thousand CNY | -95.61% |
| 2013 FY | - CNY | 5.4% |
| 2013 Q1 | 40.92 Million CNY | -55.03% |
| 2013 Q3 | 29.83 Million CNY | -40.92% |
| 2013 Q4 | 76.15 Million CNY | 155.26% |
| 2013 Q2 | 50.49 Million CNY | 23.38% |
| 2012 FY | - CNY | 20.48% |
| 2012 Q1 | 32.71 Million CNY | -38.53% |
| 2012 Q2 | 39.44 Million CNY | 20.57% |
| 2012 Q3 | 22.81 Million CNY | -42.15% |
| 2012 Q4 | 91.01 Million CNY | 298.88% |
| 2011 Q2 | 51.06 Million CNY | 74.5% |
| 2011 Q4 | 53.22 Million CNY | 54.89% |
| 2011 Q1 | 29.26 Million CNY | -6.73% |
| 2011 FY | - CNY | 33.0% |
| 2011 Q3 | 34.36 Million CNY | -32.71% |
| 2010 Q1 | 29.49 Million CNY | 13.69% |
| 2010 FY | - CNY | 20.18% |
| 2010 Q4 | 31.37 Million CNY | 21.3% |
| 2010 Q3 | 25.86 Million CNY | -29.86% |
| 2010 Q2 | 36.88 Million CNY | 25.03% |
| 2009 FY | - CNY | 40.22% |
| 2009 Q3 | 25.61 Million CNY | 0.0% |
| 2009 Q4 | 25.94 Million CNY | 1.31% |
| 2008 FY | - CNY | 31.21% |
| 2007 FY | - CNY | 0.0% |